Showing 81 - 100 results of 160 for search '"Атеротромбоз"', query time: 0.05s Refine Results
  1. 81
    SUMMARY OF CONCLUSIONS FROM A CONSENSUS PANEL OF EXPERTS ON THE IMPORTANCE OF RIVAROXABAN IN THE MANAGEMENT OF PATIENTS RECOVERING FROM ACUTE CORONARY SYNDROME

    SUMMARY OF CONCLUSIONS FROM A CONSENSUS PANEL OF EXPERTS ON THE IMPORTANCE OF RIVAROXABAN IN THE MANAGEMENT OF PATIENTS RECOVERING FROM ACUTE CORONARY SYNDROME by M. Ya. Ruda, A. I. Syrkin, E. P. Panchenko, I. S. Yavelov, O. V. Averkov, R. M. Shahnovich, A. L. Komarov

    Published 2015-12-01
    “…Атеротромбоз…”
    Get full text
    Article
    Save to List
    Saved in:
  2. 82
    THROMBOSIS IN CANCER. PART 2

    THROMBOSIS IN CANCER. PART 2 by Yu. A. FEDOTKINA, E. P. PANCHENKO

    Published 2017-12-01
    “…Атеротромбоз…”
    Get full text
    Article
    Save to List
    Saved in:
  3. 83
    АЦЕТИЛСАЛИЦИЛОВАЯ КИСЛОТА КАК ПРОФИЛАКТИЧЕСКОЕ АНТИТРОМБОТИЧЕСКОЕ СРЕДСТВО. НАЧАЛО КОНЦА БЕСКОНЕЧНОЙ ИСТОРИИ?

    АЦЕТИЛСАЛИЦИЛОВАЯ КИСЛОТА КАК ПРОФИЛАКТИЧЕСКОЕ АНТИТРОМБОТИЧЕСКОЕ СРЕДСТВО. НАЧАЛО КОНЦА БЕСКОНЕЧНОЙ ИСТОРИИ?... by О. В. Аверков

    Published 2013-07-01
    “…Атеротромбоз…”
    Get full text
    Article
    Save to List
    Saved in:
  4. 84
    АМЕРИКАНСКИЕ РЕКОМЕНДАЦИИ ACC/AHA 2013 ПО КОНТРОЛЮ ДИСЛИПИДЕМИИ: ЧТО НОВОГО И ПОЛЕЗНОГО ОНИ СОДЕРЖАТ ДЛЯ ПРАКТИЧЕСКОГО ВРАЧА? (ЛЕКЦИЯ)

    АМЕРИКАНСКИЕ РЕКОМЕНДАЦИИ ACC/AHA 2013 ПО КОНТРОЛЮ ДИСЛИПИДЕМИИ: ЧТО НОВОГО И ПОЛЕЗНОГО ОНИ СОДЕРЖАТ ДЛЯ ПРАКТИЧЕСКОГО ВРАЧА? (ЛЕКЦИЯ)...

    Published 2014-12-01
    “…Атеротромбоз…”
    Get full text
    Article
    Save to List
    Saved in:
  5. 85
    Modern possibilities and prospects in evaluating the anticoagulant effect of direct oral anticoagulants

    Modern possibilities and prospects in evaluating the anticoagulant effect of direct oral anticoagulants by A. I. Mironova, E. S. Kropacheva, A. B. Dobrovolsky, E. V. Titaeva, E. P. Panchenko

    Published 2022-06-01
    “…Атеротромбоз…”
    Get full text
    Article
    Save to List
    Saved in:
  6. 86
    Features of myocardial characteristics of patients with acute ST-segment elevation myocardial infarction with diabetes mellitus as assessed by contrast-enhanced cardiac magnetic resonance imaging

    Features of myocardial characteristics of patients with acute ST-segment elevation myocardial infarction with diabetes mellitus as assessed by contrast-enhanced cardiac magnetic re... by O. V. Stukalova, Yu. O. Shalaginova, R. M. Shakhnovich, A. G. Komarova, N. L. Lyakhova, S. K. Ternovoy, I. I. Staroverov

    Published 2023-08-01
    “…Атеротромбоз…”
    Get full text
    Article
    Save to List
    Saved in:
  7. 87
    КЛИНИЧЕСКОЕ НАБЛЮДЕНИЕ: ВРОЖДЕННЫЕ ТРОМБОФИЛИИ КАК ПРИЧИНА РАЗВИТИЯ ТРОМБОТИЧЕСКИХ ОСЛОЖНЕНИЙ В МОЛОДОМ ВОЗРАСТЕ

    КЛИНИЧЕСКОЕ НАБЛЮДЕНИЕ: ВРОЖДЕННЫЕ ТРОМБОФИЛИИ КАК ПРИЧИНА РАЗВИТИЯ ТРОМБОТИЧЕСКИХ ОСЛОЖНЕНИЙ В МОЛОДОМ ВОЗРАСТЕ... by Е. В. Гуськова, А. Л. Комаров, Е. П. Панченко

    Published 2013-12-01
    “…Атеротромбоз…”
    Get full text
    Article
    Save to List
    Saved in:
  8. 88
    ФАРМАКОГЕНЕТИКА ВАРФАРИНА

    ФАРМАКОГЕНЕТИКА ВАРФАРИНА by Е. С. Кропачева

    Published 2015-07-01
    “…Атеротромбоз…”
    Get full text
    Article
    Save to List
    Saved in:
  9. 89
    PHARMACOGENETICS OF ANTITHROMBOTIC DRUGS: STATUS UPDATE ON THE PROBLEM

    PHARMACOGENETICS OF ANTITHROMBOTIC DRUGS: STATUS UPDATE ON THE PROBLEM by Ekaterina S. Kropacheva

    Published 2018-12-01
    “…Атеротромбоз…”
    Get full text
    Article
    Save to List
    Saved in:
  10. 90
    THE SPECIFICS OF PRESCRIBING TRIPLE ANTITROMBOTIC THERAPY WITH RIVAROXABAN IN PATIENTS WITH ATRIAL FIBRILLATION AFTER CORONARY ARTERY STENTING

    THE SPECIFICS OF PRESCRIBING TRIPLE ANTITROMBOTIC THERAPY WITH RIVAROXABAN IN PATIENTS WITH ATRIAL FIBRILLATION AFTER CORONARY ARTERY STENTING by N. A. Novikova, A. S. Shilova

    Published 2017-05-01
    “…Атеротромбоз…”
    Get full text
    Article
    Save to List
    Saved in:
  11. 91
    PRASUGREL: FREQUENTLY ASKED QUESTIONS FROM PRACTITIONERS

    PRASUGREL: FREQUENTLY ASKED QUESTIONS FROM PRACTITIONERS by O. O. Shakhmatova, E. P. Panchenko

    Published 2019-06-01
    “…Атеротромбоз…”
    Get full text
    Article
    Save to List
    Saved in:
  12. 92
    IDARUCIZUMAB, A SPECIFIC REVERSAL AGENT FOR DABIGATRAN: THE PRESENT-DAY KNOWLEDGE

    IDARUCIZUMAB, A SPECIFIC REVERSAL AGENT FOR DABIGATRAN: THE PRESENT-DAY KNOWLEDGE by Olga O. Shakhmatova

    Published 2018-12-01
    “…Атеротромбоз…”
    Get full text
    Article
    Save to List
    Saved in:
  13. 93
    Management of ischemic risk events in patients with multifocal atherosclerosis and type 2 diabetes mellitus

    Management of ischemic risk events in patients with multifocal atherosclerosis and type 2 diabetes mellitus by O. L. Barbarash, V. V. Kashtalap

    Published 2020-06-01
    “…Атеротромбоз…”
    Get full text
    Article
    Save to List
    Saved in:
  14. 94
    NEW PROSPECTS IN THE SECONDARY PREVENTION OF VENOUS THROMBOSIS

    NEW PROSPECTS IN THE SECONDARY PREVENTION OF VENOUS THROMBOSIS by P. S. Laguta

    Published 2016-07-01
    “…Атеротромбоз…”
    Get full text
    Article
    Save to List
    Saved in:
  15. 95
    EXPERIENCE IN THE MANAGEMENT OF OCCLUSIVE DEEP VENUS THROMBOSIS WITH ENOXAPARININ SODIUM IN OUTPATIENT SETTINGS

    EXPERIENCE IN THE MANAGEMENT OF OCCLUSIVE DEEP VENUS THROMBOSIS WITH ENOXAPARININ SODIUM IN OUTPATIENT SETTINGS by A. M. ZUDIN, A. G. FAIBUSHEVICH

    Published 2017-12-01
    “…Атеротромбоз…”
    Get full text
    Article
    Save to List
    Saved in:
  16. 96
    Current views on antiplatelet therapy in acute coronary syndrome patients: the place of clopidogrel

    Current views on antiplatelet therapy in acute coronary syndrome patients: the place of clopidogrel by O. O. Shakhmatova

    Published 2022-06-01
    “…Атеротромбоз…”
    Get full text
    Article
    Save to List
    Saved in:
  17. 97
    ЭХО АТЕРОШКОЛ

    ЭХО АТЕРОШКОЛ by статья Редакционная

    Published 2013-07-01
    “…Атеротромбоз…”
    Get full text
    Article
    Save to List
    Saved in:
  18. 98
    Antithrombotic therapy in patients with atrial fibrillation and percutaneous coronary intervention: what has changed in the guidelines in 2020?

    Antithrombotic therapy in patients with atrial fibrillation and percutaneous coronary intervention: what has changed in the guidelines in 2020? by E. P. Panchenko

    Published 2020-12-01
    “…Атеротромбоз…”
    Get full text
    Article
    Save to List
    Saved in:
  19. 99
    HAVE WE SHIFTED OUR PARADIGM OF CLOPIDOGREL AS A MANDATORY DRUG IN TREATMENT OF CARDIOLOGICAL PATIENTS AFTER THE INTRODUCTION OF MORE POWERFUL ANTIAGREGANTS?

    HAVE WE SHIFTED OUR PARADIGM OF CLOPIDOGREL AS A MANDATORY DRUG IN TREATMENT OF CARDIOLOGICAL PATIENTS AFTER THE INTRODUCTION OF MORE POWERFUL ANTIAGREGANTS? by E. P. PANCHENKO

    Published 2017-12-01
    “…Атеротромбоз…”
    Get full text
    Article
    Save to List
    Saved in:
  20. 100
    A STRATEGY FOR MANAGING A PATIENT WITH ATRIAL FIBRILLATION TO REDUCE THE RISK OF THROMBOEMBOLIC COMPLICATIONS

    A STRATEGY FOR MANAGING A PATIENT WITH ATRIAL FIBRILLATION TO REDUCE THE RISK OF THROMBOEMBOLIC COMPLICATIONS by L. I. Kudryavtseva, E. V. Filippov

    Published 2019-06-01
    “…Атеротромбоз…”
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: